Assignee
MEMGEN INC
US·2 granted patents·2 pending applications·0 citations·filing 2018–2022
Top patents by PatentIndex Score
4 records- 0155US2023270784A1Oncolytic virus boosts t cell response for effective til therapyMEMGEN INC·Filed 2022·Application pending·0 cites
- 0254US2022090134A1Enhancing Immunity Using Chimeric CD40 Ligand and Coronavirus VaccineMEMGEN INC·Filed 2021·Application pending·0 cites
- 0345US12171803B2Methods of CD40 and toll like receptor immune activationMEMGEN INC·Filed 2018·Granted Dec 24, 2024·0 cites·10 claims
- 0445US11951141B2Replication-enhanced oncolytic adenovirusesMEMGEN INC·Filed 2020·Granted Apr 9, 2024·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →